Antifungal Drugs Market to Hit USD 25.0 Billion by 2030, Exclusive Report

According to the report published by Allied Market Research, the global Antifungal Drugs Market generated $16.6 billion in 2020, and is projected to reach $25.0 billion by 2030, witnessing a CAGR of 3.9% from 2021 to 2030. The study analyzes the important strategies, drivers, competition, market dynamics, size, and important investment regions.

Key Takeaways:

• The antifungal drugs market is experiencing significant growth and is expected to continue expanding in the coming years.
• The increasing prevalence of fungal infections, especially among immunocompromised individuals, is a major driver for the market growth.
• The development of new and more effective antifungal drugs is contributing to market expansion.
• Azoles, echinocandins, and polyenes are the major classes of antifungal drugs in use today.
• The oral antifungal drugs segment holds a significant share in the market due to their ease of administration and effectiveness.
• The hospital pharmacies segment dominates the distribution channel, followed by retail pharmacies and online pharmacies.
• North America and Europe are the leading regional markets for antifungal drugs, attributed to advanced healthcare infrastructure and high awareness about fungal infections.

Request Sample Copy of the Report: 

https://www.alliedmarketresearch.com/request-sample/2370

Market Drivers:

Increasing prevalence of fungal infections: The growing incidence of fungal infections, particularly among immunocompromised individuals such as those with HIV/AIDS, cancer patients undergoing chemotherapy, and organ transplant recipients, is a significant driver for the market. Fungal infections can be life-threatening if not treated promptly and effectively, necessitating the use of antifungal drugs.

Rising awareness and diagnosis: There is a growing awareness about fungal infections among healthcare professionals and the general population, leading to improved diagnosis rates. As a result, more patients are being diagnosed with fungal infections and requiring antifungal treatment.

Advances in antifungal drug development: The development of new and more effective antifungal drugs is driving market growth. Pharmaceutical companies are investing in research and development to create novel antifungal therapies with improved efficacy, safety, and broader spectrum of activity against different types of fungi.

Market Segmentation:

1. Drug Class: Antifungal drugs can be classified into different classes based on their mechanism of action. The major classes include:

• Azoles
• Echinocandins
• Polyenes

1. Route of Administration: Antifungal drugs can be administered via various routes, including:

• Oral
• Topical
• Intravenous

1. Indication: Antifungal drugs are used to treat a wide range of fungal infections affecting different parts of the body, including:

• Systemic fungal infections
• Superficial fungal infections

1. Distribution Channel: The market can be segmented based on the distribution channels through which antifungal drugs are sold, including:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Geographically, the market can be segmented into regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Request for Customization – https://www.alliedmarketresearch.com/request-for-customization/2370

Regional Growth Dynamics:

North America contributed to the highest share in terms of revenue in 2020, holding more than two-fifths of the total market share, and is estimated to continue its dominant share by 2030. However, Asia-Pacific is projected to manifest the fastest CAGR of 5.2% during the forecast period.

Competitive Landscape:

• Pfizer Inc.
• Novartis AG
• Merck & Co., Inc.
• Astellas Pharma Inc.
• GlaxoSmithKline plc
• Johnson & Johnson Services, Inc.
• Sanofi S.A.
• Bayer AG
• Mylan N.V.
• Gilead Sciences, Inc.

Recent developments:

• Development of Novel Antifungal Agents: Pharmaceutical companies are actively engaged in the development of novel antifungal drugs with improved efficacy and safety profiles. For example, new triazole antifungal agents like isavuconazole and ibrexafungerp have been approved for the treatment of invasive fungal infections.
• Combination Therapies: Combination therapies involving multiple antifungal drugs are being explored to enhance treatment outcomes, especially in difficult-to-treat fungal infections. Combinations of azoles, echinocandins, and polyenes are being studied to improve effectiveness and overcome resistance.
• Expanded Indications: Some antifungal drugs are being investigated for expanded indications beyond their initial approved uses. For instance, certain azole drugs are being explored for their potential in the treatment of fungal sinusitis and fungal keratitis.

Buy this Premium Research Report: 

https://www.alliedmarketresearch.com/purchase-enquiry/2370

VALUE PROPOSITIONS RELATED TO THE REPORT:

• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
• Comprehensive quantitative and qualitative insights at segment and sub-segment level
• Covid 19 impact trends and perspective
• Granular insights at global/regional/country level
• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment

Get an access to the library of reports at any time from any device and anywhere. For more details, follow the

https://www.alliedmarketresearch.com/library-access

Browse more latest healthcare reports:

Erythropoietin Drugs Market by Product Type (Epoetin-Alfa, Epoetin-Beta, and Darbepoetin-Alfa, Others) and Application (Hematology, Kidney Disorder, Cancer, Others): Global Opportunity Analysis and Industry Forecast, 2021-2028

Brachytherapy Market By Product Type (Seeds, Applicators and Afterloaders, Electronic Brachytherapy), By Technique (High Dose Rate (HDR), Low Dose Rate (LDR)), By Application (Gynecological Cancer, Prostate Cancer, Breast Cancer, Others), By End User (Hospitals, Specialty Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com